Managed Access Programs for LDK378, Ceritinib

Clinical trial NCT05100134 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT05100134
Sponsor: Novartis Pharmaceuticals
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Anaplastic Lymphoma Kinase (ALK)- Positive Tumors Non-small Cell Lung Cancer (NSCLC)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.